The Allo Hope Foundation, founded in 2019, focuses on offering resources and support for alloimmunized women suffering from Hemolytic Disease of the Fetus and Newborn (HDFN). The foundation provides education, advocacy, and patient-centered care while promoting awareness and research initiatives to improve outcomes for affected families globally.
2019
84-2785519
$124.7 thousand
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Engage with the Allo Hope Foundation through sharing stories or participating in initiatives.
Access educational booklets and resources about HDFN for patients and providers.
Discover the various support resources available for those affected by alloimmunization.
Established Patient Support Programs
Development of a support network for women affected by alloimmunization and HDFN.
Launched The Allo Podcast
Sharing valuable insights and patient stories related to alloimmunization.
World Alloimmunization & HDFN Awareness Day
March 12th recognized as a day to raise awareness about alloimmunization and HDFN.
2023-04-19
Presentation at ACOG Conference to discuss advancements in HDFN treatments.
2022-03-12
Celebration of the first Alloimmunization Awareness Day.
2023-05-20
Participation in the THOR Symposium 2023 for maternal fetal medicine.
Overall Score
46
54
/100
Program Expense Ratio
98.47%
20
/20
Program Revenue Growth
-100.00%
2
/20
Leverage Ratio
0.05903
20
/20
Working Capital Ratio
0.8337
10
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 325.6K | 99.85% |
Program Services | 0 | 0.00% |
Investment Income | 25 | 0.01% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 474 | 0.15% |
Total Revenue | 326.1K | 100.00% |